200 related articles for article (PubMed ID: 36996860)
21. Correlates of anti-hepatitis C positivity and use of harm reduction services among people who inject drugs in two cities in Croatia.
Handanagic S; Sevic S; Barbaric J; Dominkovic Z; Dakovic Rode O; Begovac J; Bozicevic I
Drug Alcohol Depend; 2017 Feb; 171():132-139. PubMed ID: 28088084
[TBL] [Abstract][Full Text] [Related]
22. Gaps in hepatitis C virus prevention and care for HIV-hepatitis C virus co-infected people who inject drugs in Canada.
Lanièce Delaunay C; Maheu-Giroux M; Marathe G; Saeed S; Martel-Laferrière V; Cooper CL; Walmsley S; Cox J; Wong A; Klein MB;
Int J Drug Policy; 2022 May; 103():103627. PubMed ID: 35218989
[TBL] [Abstract][Full Text] [Related]
23. Using a programmatic mapping approach to plan for HIV prevention and harm reduction interventions for people who inject drugs in three South African cities.
Scheibe A; Shelly S; Lambert A; Schneider A; Basson R; Medeiros N; Padayachee K; Savva H; Hausler H
Harm Reduct J; 2017 Jun; 14(1):35. PubMed ID: 28592246
[TBL] [Abstract][Full Text] [Related]
24. The cost-effectiveness of harm reduction.
Wilson DP; Donald B; Shattock AJ; Wilson D; Fraser-Hurt N
Int J Drug Policy; 2015 Feb; 26 Suppl 1():S5-11. PubMed ID: 25727260
[TBL] [Abstract][Full Text] [Related]
25. "We get by with a little help from our friends": Small-scale informal and large-scale formal peer distribution networks of sterile injecting equipment in Australia.
Newland J; Newman C; Treloar C
Int J Drug Policy; 2016 Aug; 34():65-71. PubMed ID: 27449331
[TBL] [Abstract][Full Text] [Related]
26. Understanding hepatitis B, hepatitis C and HIV among people who inject drugs in South Africa: findings from a three-city cross-sectional survey.
Scheibe A; Young K; Moses L; Basson RL; Versfeld A; Spearman CW; Sonderup MW; Prabdial-Sing N; Manamela J; Puren AJ; Rebe K; Hausler H
Harm Reduct J; 2019 Apr; 16(1):28. PubMed ID: 30975139
[TBL] [Abstract][Full Text] [Related]
27. Interventions to prevent HIV and Hepatitis C among people who inject drugs: Latest evidence of effectiveness from a systematic review (2011 to 2020).
Palmateer N; Hamill V; Bergenstrom A; Bloomfield H; Gordon L; Stone J; Fraser H; Seyler T; Duan Y; Tran R; Trayner K; Biggam C; Smith S; Vickerman P; Hickman M; Hutchinson S
Int J Drug Policy; 2022 Nov; 109():103872. PubMed ID: 36202039
[TBL] [Abstract][Full Text] [Related]
28. Access to needles and syringes and methadone maintenance therapy among people who inject drugs in Yangon, Myanmar: a qualitative study.
Yee WL; Draper B; Myint KT; Min W; Htay H; O'Keefe D; Hellard M
Harm Reduct J; 2022 Sep; 19(1):107. PubMed ID: 36175872
[TBL] [Abstract][Full Text] [Related]
29. Service utilization and cost of implementing a comprehensive HIV prevention and care program among people who inject drugs in Delhi, India.
Sebastian MP; Dasgupta A; Saraswati LR; Singh A; Sharma V; Madan I; Tun W; Pulerwitz J; Thior I; Sarna A
Harm Reduct J; 2017 Jun; 14(1):38. PubMed ID: 28615077
[TBL] [Abstract][Full Text] [Related]
30. Estimating the number of people who inject drugs using repeated respondent-driven sampling (RDS) in a community-based program: implications for the burden of hepatitis C and HIV infections and harm reduction coverage.
Roussos S; Paraskevis D; Malliori M; Hatzakis A; Sypsa V
AIDS Behav; 2023 Feb; 27(2):424-430. PubMed ID: 35947234
[TBL] [Abstract][Full Text] [Related]
31. Injecting risk behaviours amongst people who inject drugs: A global multi-stage systematic review and meta-analysis.
Tran LT; Peacock A; Colledge S; Memedovic S; Grebely J; Leung J; Larney S; Trickey A; Stone J; Vickerman P; Hickman M; Degenhardt L
Int J Drug Policy; 2020 Oct; 84():102866. PubMed ID: 32712484
[TBL] [Abstract][Full Text] [Related]
32. Incidence and factors associated with discontinuation of opioid agonist therapy among people who inject drugs in Australia.
Geddes L; Iversen J; Wand H; Maher L
Addiction; 2021 Mar; 116(3):525-535. PubMed ID: 32557931
[TBL] [Abstract][Full Text] [Related]
33. Effectiveness of needle and syringe Programmes in people who inject drugs - An overview of systematic reviews.
Fernandes RM; Cary M; Duarte G; Jesus G; Alarcão J; Torre C; Costa S; Costa J; Carneiro AV
BMC Public Health; 2017 Apr; 17(1):309. PubMed ID: 28399843
[TBL] [Abstract][Full Text] [Related]
34. Design, implementation, and monitoring of HIV service packages for people who inject drugs: An assessment of programs supported by the Global Fund in 46 countries.
Burrows D; Falkenberry H; McCallum L; Parsons D; Ngoksin E; Zhao J; Kunii O
Int J Drug Policy; 2021 Feb; 88():103036. PubMed ID: 33212370
[TBL] [Abstract][Full Text] [Related]
35. The impact of the COVID-19 pandemic on people who inject drugs accessing harm reduction services in an rural American state.
Thakarar K; Kohut M; Hutchinson R; Bell R; Loeb HE; Burris D; Fairfield KM
Harm Reduct J; 2022 Jul; 19(1):80. PubMed ID: 35869523
[TBL] [Abstract][Full Text] [Related]
36. Optimal provision of needle and syringe programmes for injecting drug users: A systematic review.
Jones L; Pickering L; Sumnall H; McVeigh J; Bellis MA
Int J Drug Policy; 2010 Sep; 21(5):335-42. PubMed ID: 20189375
[TBL] [Abstract][Full Text] [Related]
37. Unit costs of needle and syringe program provision: a global systematic review and cost extrapolation.
Killion JA; Magana C; Cepeda JA; Vo A; Hernandez M; Cyr CL; Heskett KM; Wilson DP; Graff Zivin J; Zúñiga ML; Pines HA; Garfein RS; Vickerman P; Terris-Prestholt F; Wynn A; Martin NK
AIDS; 2023 Dec; 37(15):2389-2397. PubMed ID: 37773035
[TBL] [Abstract][Full Text] [Related]
38. HIV incidence among people who inject drugs in the Middle East and North Africa: mathematical modelling analysis.
Mumtaz GR; Awad SF; Feizzadeh A; Weiss HA; Abu-Raddad LJ
J Int AIDS Soc; 2018 Mar; 21(3):e25102. PubMed ID: 29577623
[TBL] [Abstract][Full Text] [Related]
39. Take-home naloxone possession among people who inject drugs in rural West Virginia.
Allen ST; White RH; O'Rourke A; Grieb SM; Kilkenny ME; Sherman SG
Drug Alcohol Depend; 2019 Nov; 204():107581. PubMed ID: 31574407
[TBL] [Abstract][Full Text] [Related]
40. Modelling the impact of HIV and HCV prevention and treatment interventions for people who inject drugs in Dar es Salaam, Tanzania.
Fraser H; Stone J; Wisse E; Sambu V; Mfisi P; Duran IJ; Soriano MA; Walker JG; Makere N; Luhmann N; Kafura W; Nouvellet M; Ragi A; Mundia B; Vickerman P
J Int AIDS Soc; 2021 Oct; 24(10):e25817. PubMed ID: 34661964
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
